Successful Use of Recombinant Factor VIIa in a Patient with Intractable Bleeding During Extracorporeal Membrane Oxygenation

Abstract

Bleeding is still the most common complication during extracorporeal membrane oxygenation (ECMO) for temporary cardio-circulatory support. We present a case of a young man suffering from intractable hemorrhage during ECMO support, who was pre-treated with glycoprotein IIb/IIIa receptor antagonist Tirofiban due to a suspicion of myocardial ischemia. After failure of conventional hemostatic means, hemostasis was achieved by the donation of recombinant Factor VIIa (rFVIIa). Aspects of bleeding control during extracorporeal circulatory support, the use of Tirofiban and rFVIIa are discussed.

Recombinant Factor VIIa - extracorporeal membrane oxygenation (ECMO) - bleeding - Tirofiban

References

• 1 Smith C, Bellomo R, Raman J S, Matalanis G, Rosalion A, Buckmaster J, Hart G, Silvester W, Gutteridge G A, Smith B, Doolan L, Buxton B F. An extracorporeal membrane oxygenation-based approach to cardiogenic shock in older population.  Ann Thorac Surg. 2001;  71 1421-1427
• 2 Doll N, Kiaii B, Borger M, Bucerius J, Krämer K, Schmitt D V, Walther T, Mohr F W. Five-year results of 219 consecutive patients treated with Extracorporeal Membrane Oxygenation for refractory postoperative cardiogenic shock.  Ann Thorac Surg. 2004;  77 151-17l
• 3 Patrano C. for the Task Force on the Use of Antiplatelet Agents in Patients with Arteriosclerotic Cardiovascular Disease of the European Society of Cardiology . Expert consensus document on the use of antiplatelet agents.  Eur Heart J. 2004;  25 166-181
• 4 Brown D L. Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment.  Heart. 2003;  89 535-537
• 5 Hedner U. Recombinant factor VIIa (NovoSeven) as a haemostatic agent.  Dis Mon. 2003;  49 39-48
• 6 Hendricks H GD, van der Maarten J MAA, deWolf J, Waterbolk W TW, Slooff M JH, van der Meer J. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII.  Anesth Analg. 2001;  93 287-289